## NBIX: Neurocrine Biosciences, Inc. - XLV: Healthcare

### Executive Summary

VALUE thesis: PEG 0.27 indicates fundamental undervaluation.

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($133.02)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. 13,364 Shares in Neurocrine Biosciences, Inc. $NBIX Acquired by Pacer Advisors Inc.**
- Source: MarketBeat | 20260101T110933 | Bullish | Relevance: 100%
- Pacer Advisors Inc. recently acquired 13,364 shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) valued at approximately $1.876 million. This acquisition follows Neurocrine's strong Q3 performance, which saw an EPS of $2.17 and revenues of $794.9 million, surpassing analyst estimates. The stock is largely favored by analysts, with a "Moderate Buy" consensus and an average target price of $175.25.

**2. Neurocrine Biosciences (NASDAQ:NBIX) Downgraded by Zacks Research to "Hold"**
- Source: MarketBeat | 20251231T120855 | Neutral | Relevance: 100%
- Zacks Research has downgraded Neurocrine Biosciences (NASDAQ:NBIX) from "strong-buy" to "hold" as of Monday, December 29th, 2025, despite the company reporting a strong Q3 beat with $2.17 EPS and $794.9M revenue. The consensus among other analysts, however, remains a "Moderate Buy" with an average target price of $175.25. Insider selling activity totaling 43,866 shares ($6.57M) occurred over the last quarter, while institutional investors hold a significant 92.59% of the stock.

**3. VIRGINIA RETIREMENT SYSTEMS ET Al Boosts Stake in Neurocrine Biosciences, Inc. $NBIX**
- Source: MarketBeat | 20260101T110933 | Somewhat-Bullish | Relevance: 98%
- Virginia Retirement Systems increased its stake in Neurocrine Biosciences by 15.6% during Q3, now owning 98,423 shares valued at approximately $13.8 million. The company reported strong Q3 earnings, beating analyst expectations with an EPS of $2.17 and revenue of $794.9 million. Despite institutional buying, company insiders have sold 43,866 shares in the last 90 days.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | HC Wainwright & | $198 | $168 | +18% |
| 2025-12-12 | Mizuho | $175 | $146 | +20% |
| 2025-12-11 | Stifel | $188 | $183 | +3% |
| 2025-12-08 | RBC Capital | $180 | $160 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | HC Wainwright & | main | Buy |
| 2025-12-12 | Mizuho | main | Neutral |
| 2025-12-11 | Stifel | main | Buy |
| 2025-12-08 | RBC Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 10 ($2.96M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Blackrock Inc.: 12.7% (-1.9%)
- Vanguard Group Inc: 9.7% (-1.0%)
- JPMORGAN CHASE & CO: 9.5% (+122.0%)
- Dodge & Cox Inc.: 5.6% (-0.2%)
- State Street Corpora: 4.4% (-2.7%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 5 raises (avg +13%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.27 indicates undervaluation relative to growth. Forward P/E 15.3x attractive for 33% earnings growth. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (3.4x), low leverage (D/E 0.42). Analyst sentiment positive (5 raises, avg +13%). Insider selling cluster ($3.0M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $14.0B |
| Beta | 0.27 |
| 52W Range | $84.23 - $160.18 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.27 |
| Forward P/E | 15.3 |
| Current P/E | 20.3 |
| YoY Growth | 32.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -4.7% (minimal 5-day change). Below STRENGTH zone by 8.7pp (needs >4.0% for momentum thesis). AM_20 at -5.3% indicates price below own 20MA trend. Underperforming sector by 6.3pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). MACD histogram bearish (-1.11), momentum weakening. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.71% (CS: 8) | Weak |
| RSI_14 | 38.2 | Neutral |
| MACD Histogram | -1.11 | Bearish |
| vs SMA20 | 0.947x | Below |
| vs SMA50 | 0.958x | Below |
| vs SMA200 | 1.073x | Above |

### Decision

- **Verdict:** HOLD
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $140.60
- **Stop Loss:** $133.02 (5.4% risk)
- **Target:** $155.76 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 189
- **Position Value:** $26,573.40
- **Portfolio %:** 26.57%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-05 (Est: $2.41)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.07 | $2.17 | +4.9% |
| 2025Q2 | $1.50 | $1.65 | +9.6% |
| 2025Q1 | $1.09 | $0.70 | -36.0% |
| 2024Q4 | $1.93 | $1.69 | -12.4% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*